Hypofractionated palliative radiotherapy for metastatic lung cancer patients is frequently used in order to ease pain, to increase bone stability, to treat local mass effects, or to prolong progression-free survival at critical sites. | Fostering efficacy of anti-PD-1-treatment Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial